Correlation Between Dynavax Technologies and Kalvista Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and Kalvista Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and Kalvista Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynavax Technologies and Kalvista Pharmaceuticals, you can compare the effects of market volatilities on Dynavax Technologies and Kalvista Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of Kalvista Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and Kalvista Pharmaceuticals.
Diversification Opportunities for Dynavax Technologies and Kalvista Pharmaceuticals
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Dynavax and Kalvista is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and Kalvista Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalvista Pharmaceuticals and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with Kalvista Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalvista Pharmaceuticals has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and Kalvista Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dynavax Technologies and Kalvista Pharmaceuticals
Given the investment horizon of 90 days Dynavax Technologies is expected to under-perform the Kalvista Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Dynavax Technologies is 4.31 times less risky than Kalvista Pharmaceuticals. The stock trades about -0.14 of its potential returns per unit of risk. The Kalvista Pharmaceuticals is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 809.00 in Kalvista Pharmaceuticals on October 20, 2024 and sell it today you would earn a total of 21.00 from holding Kalvista Pharmaceuticals or generate 2.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dynavax Technologies vs. Kalvista Pharmaceuticals
Performance |
| Timeline |
| Dynavax Technologies |
| Kalvista Pharmaceuticals |
Dynavax Technologies and Kalvista Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dynavax Technologies and Kalvista Pharmaceuticals
The main advantage of trading using opposite Dynavax Technologies and Kalvista Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, Kalvista Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will offset losses from the drop in Kalvista Pharmaceuticals' long position.| Dynavax Technologies vs. Alkermes Plc | Dynavax Technologies vs. Neurocrine Biosciences | Dynavax Technologies vs. Intracellular Th | Dynavax Technologies vs. Aquestive Therapeutics |
| Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | Kalvista Pharmaceuticals vs. Kura Oncology | Kalvista Pharmaceuticals vs. Viridian Therapeutics | Kalvista Pharmaceuticals vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |